1
|
Rao V, Kannan S, Kumar J, Arakeri G, Subash A, Batra HV, Gulia A. COVID-19: An insight into the developments in diagnostics and therapeutics in India. ACTA ACUST UNITED AC 2020. [PMCID: PMC7485634 DOI: 10.25259/ijms_152_2020] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
The unexpected pandemic set off by the novel coronavirus (SARS-CoV2) has spread to more than 210 countries across the globe, including India. In the current pandemic situation, various steps have been taken by the Indian government to prevent and control the spread of the SARS-CoV2 infection. To date, there are no proven vaccines or effective therapeutic interventions against the virus. Current clinical management includes infection prevention and control, symptom-specific relief and supportive care. Physicians and scientists across the country have been tirelessly working on developing effective diagnostic and therapeutic strategies and to combat and control this infection. As the demand for diagnostics and therapeutics continues to rise in India and around the globe, it is essential to rapidly develop various algorithms to successfully identify and contain the virus. This review discusses the updates on the recent developments in COVID-19 diagnostics and therapeutics in India.
Collapse
Affiliation(s)
- Vishal Rao
- Department of Head and Neck Surgical Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India,
| | - Swetha Kannan
- Department of Head and Neck Surgical Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India,
- School of Biological Sciences, University of Edinburgh, Edinburgh, UK,
| | - Jitendra Kumar
- Bangalore Bio-Innovation Centre, Helix Biotech Park, Electronics City Phase 1, Electronic City, Bengaluru, Karnataka, India,
| | - Gururaj Arakeri
- Department of Oral and Maxillofacial Surgery, Navodaya Dental College, Raichur, Karnataka, India,
| | - Anand Subash
- Department of Head and Neck Surgical Oncology, HCG Cancer Hospital, Bengaluru, Karnataka, India,
| | - H. V. Batra
- Bommasandra Industrial Estate, Shankaranaraya Life Sciences, Bengaluru, Karnataka, India,
| | - Ashish Gulia
- Bone and Soft Tissue, Tata Memorial Hospital, Mumbai, Maharashtra, India,
| |
Collapse
|